Nontuberculous Mycobacterial Infection: CT Scan Findings, Genotype, and Treatment Responsiveness

Study objective: The purpose of this study was to compare the imaging findings of nontuberculous mycobacterial (NTM) infection in patients with normal and abnormal cystic fibrosis (CF) genotypes, and normal and abnormal α 1 -antitrypsin (AAT) phenotypes. Design: A retrospective review of medical records and chest CT scans from 85 patients with microbiologically proven NTM infection was performed. All patients had undergone genotype analysis for CF mutations, and phenotypic evaluation for AAT status. Patients with homozygous CF or AAT were not included. Two independent observers assessed the patterns and distribution of disease, according to a standardized score sheet. In 52 patients, follow-up CT scans were obtained 1 to 46 months (mean duration, 8 months) following the initial CT scan. The CT scan findings on the follow-up scan were visually compared with those on the initial CT scan for progression or regression of abnormalities. Statistical analysis was performed to evaluate the relationship between the dominant CT scan pattern and CF/AAT status, and between CT scan pattern and radiologic change on follow-up. Results: Fifteen patients (18%) were found to carry a single CF mutation, and an abnormal AAT phenotype was seen in 13 patients (15%). Three patients (3%) were found to have both a heterozygous CF mutation and a heterozygous AAT phenotype. On the initial CT scans, bronchiectasis and nodules were the most frequent findings of NTM infection in all three groups (p > 0.05). The prevalence of nodules was slightly lower in the CF group, and the prevalence of linear scarring was greater in the AAT group than in the normal group (p Conclusion: In patients with NTM infection, the CT scan findings show only minor differences according to phenotype and genotype. Initial CT scan findings do not predict change on follow-up CT scan evaluation. However, on follow-up CT scan, patients with CF mutations are less likely to improve, while those with AAT phenotype appear to have a radiographic outcome similar to those with normal phenotype.

[1]  G. Merriam,et al.  Radiation dose to the lens in treatment of tumors of the eye and adjacent structures: possibilities of cataract formation. , 1958, Radiology.

[2]  Ji‐Hyun Lee,et al.  Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. , 2003, American journal of respiratory and critical care medicine.

[3]  J. Haddow,et al.  Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians , 2002, Genetics in Medicine.

[4]  B. Petrini,et al.  Prospective study of mycobacterial infections in patients with cystic fibrosis. , 1990, Thorax.

[5]  M. Knowles,et al.  The I148T CFTR allele occurs on multiple haplotypes: A complex allele is associated with cystic fibrosis , 2002, Genetics in Medicine.

[6]  M. Iseman.  Mycobacterium avium Complex and the Normal Hosts , 1989 .

[7]  F. Kueppers.  Determination of alpha1-antitrypsin phenotypes by isoelectric focusing in polyacrylamide gels. , 1976, The Journal of laboratory and clinical medicine.

[8]  Ji‐Hyun Lee,et al.  Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[9]  D. Hansell,et al.  High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. , 1992, Clinical radiology.

[10]  P. Gilligan,et al.  Nontuberculous mycobacteria in adult patients with cystic fibrosis. , 1992, Chest.

[11]  W. Grody,et al.  Standards and Guidelines for CFTR Mutation Testing , 2002, Genetics in Medicine.

[12]  Rachel Booker Rgn,et al.  Chronic obstructive pulmonary disease , 1998 .

[13]  D. A. Lynch,et al.  CT Features of Pulmonary Mycobacterium avium Complex Infection , 1995, Journal of computer assisted tomography.

[14]  C. Springer,et al.  Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. , 1992, American journal of human genetics.

[15]  P. Diaz,et al.  Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. , 1996, Radiology.

[16]  David G Milne,et al.  Thin-section CT in obstructive pulmonary disease: discriminatory value. , 2002, Radiology.

[17]  K. Ho,et al.  Bronchiectasis in Patients With α1-Antitrypsin Deficiency : A Rare Occurrence? , 1993 .

[18]  D. Snider,et al.  The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. , 1987, The American review of respiratory disease.

[19]  W. Grody,et al.  Erratum: Standards and guidelines for CFTR mutation testing (Genetics in Medicine (2002) 4 (379-391)) , 2002 .

[20]  J. Pontius,et al.  The reversal of advanced bronchiectasis. , 1957, Radiology.

[21]  D. Peterson,et al.  Infection with Mycobacterium avium complex in patients without predisposing conditions. , 1989, The New England journal of medicine.

[22]  B. Ramsey,et al.  Nontuberculous mycobacterial disease in adult cystic fibrosis patients. , 1993, Chest.

[23]  E. Moore.  Atypical mycobacterial infection in the lung: CT appearance. , 1993, Radiology.

[24]  R. Heim,et al.  Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel , 2001, Genetics in medicine : official journal of the American College of Medical Genetics.

[25]  W. Grody,et al.  Cystic fibrosis carrier screening: Issues in implementation , 2002, Genetics in Medicine.